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Abstract 
We wanted to determine whether autonom-
ic dysfunction in patients with lymphoma is
related to chemotherapy or represent a parane-
oplastic syndrome. 40 patients with current or
cured Hodgkin or non-Hodgkin lymphoma and
40 healthy controls, matched for age, gender,
hypertension and diabetes mellitus underwent
autonomic evaluation (Deep Breath, Valsalva
Maneuver, Hand Grip, Lying to Standing, Tilt
Test). Current patients also suffering from dia-
betes or hypertension, or still on chemothera-
py revealed autonomic changes, while cured or
healthy subjects did not. Autonomic dysfunc-
tion in lymphoma is a transient manifestation
of a paraneoplastic syndrome.
Introduction
There  is  some  controversy  regarding  the
association  between  autonomic  dysfunction
and  Hodgkin  disease.  Some  papers  report
acute dysautonomia involving the parasympa-
thetic and sympathetic system, like a paraneo-
plastic syndrome, in Hodgkin lymphoma1-4 and
others describe improvements after the treat-
ment  of  the  disease.5 Some  studies  suggest
that such autonomic changes are related to the
malignant disease,6 but others claim that they
are the consequence of chemotherapy.7,8
Given these conflicting findings, we tried to
verify whether lymphoma per se or chemother-
apy for this disease genuinely influence the
autonomic system. We considered two groups
of patients with lymphoma: the first one was
formed by subjects who had been cured, while
the  other  one  was  constituted  by  cases  still
receiving treatment. These two groups were
matched with a control group of healthy sub-
jects. All individuals underwent to the classic
autonomic tests.
Materials and Methods
In a period of over one year, we studied 40
cases (M 20; F 20; mean age 58.7±7.3), 18 of
them of non-Hodgkin (NH) lymphoma and 22
of Hodgkin (H) lymphoma, all attending our
outpatients clinic for regular follow-up and/or
treatment. All the cured subjects had received
both  chemotherapy  (CT)  and  external  beam
radiotherapy (RT), the latest dose having been
administered  almost  a  year  previously.  The
current patients were still receiving combined
CT (including toxic agents such as vinca alka-
loids) and/or RT based on international proto-
cols. The control group was of 40 subjects (M
20; F 20; mean age 59.5±6.7) (Table 1).
All  subjects  underwent  to  the  autonomic
evaluation.
Autonomic evaluation
Subjects  underwent  cardiovascular  auto-
nomic nerve function tests,9 in the following
order:  Deep  Breathing  Test,  Valsalva  Test,
Isometric Hand Grip Test, Laying to Standing
Test and Tilt test.  In the Deep Breathing Test,
a test of vagal heart rate control,9 the duration
of the expiratory and inspiratory breaths was 5
seconds each for a total of 40 seconds (4 respi-
ratory cycles). The ratio of the longest to the
shortest  respiratory  rate  (RR)  intervals  was
determined from the ECG for each respiratory
cycle,  and  the  mean  of  the  four  ratios  was
taken as the expiratory/inspiratory (E/I) ratio. 
In the Valsalva Test, which measures both
parasympathetic  and  sympathetic  functions,
subjects blew into a manometer, maintaining
an intrathoracic pressure of 40 mmHg for 15
seconds.  The  ratio  between  the  shortest  RR
interval during the expiratory effort and the
longest  RR  interval  during  the  20  seconds
afterwards (Valsalva ratio) was calculated.
In  the  Isometric  Hand  Grip  Test,  subjects
squeezed  a  dynamometer  in  their  dominant
hand for 3 minutes using a force correspon-
ding to 30% of their maximal squeezing force.
Heart rate and blood pressure were measured
at  rest,  before  and  after  gripping  the
dynamometer.
In the Laying to Standing Test, subjects sud-
denly stood up after resting quietly in a supine
position for 5 minutes. Heart rate and blood
pressure were measured at rest and then 1, 3,
5 and 7 minutes after standing up.
In the Tilt Test, subjects laid supine on an
electric tilt table. A restraining strap, applying
a negligible pressure to the surface of the body
put  across  the  upper  abdomen,  secured  the
patients to the tilt table during the upright tilt.
Humeral  blood  pressure  and  electrocardio-
grams were recorded continuously throughout
the  test,  which  lasted  30  minutes  and  was
judged to be positive only in the case of symp-
toms  fully  reproducing  the  patient’s  original
pre-syncopal or syncopal symptoms accompa-
nied  by  arterial  hypotension,  bradycardia  or
both.10,11
Statistical analysis
Autonomic test results were compared using
Student’s two tailed t-test for matched data.
Statistical significance was set at P<0.05.
Results
Table 1 shows the general characteristics of
cases  and  controls.  Table  2  summarizes  the
results  of  the  autonomic  tests  in  current
patients and cured subjects: the latter had no
autonomic  dysfunction,  whereas  current
patients  had  altered  Deep  Breathing  Test
results and Valsalva ratios. We also evaluated
current cases and cured cases versus healthy
subjects and we found that the autonomic eval-
uation was altered only in current cases, while
cured  patients  did  not  differ  from  healthy
(Tables 3, 4). 
Discussion
Autonomic  dysfunction  is  documented  in
cases of lymphoma,5 but it is important to clar-
ify whether this is a paraneoplastic manifesta-
tion  or  a  consequence  of  chemotherapy7,12
because, in the first hypothesis, chemotherapy
can cure the alteration, while in the second
one it may exacerbate the dysfunction, with all
the well-known consequences.  In fact, auto-
nomic impairment is responsible for a higher
mortality rate due to cardiovascular disease,
such as sudden death resulting from cardiac
arrhythmia.1 Our study shows that dysautono-
mia in lymphoma is a direct consequence of
the disease and that cured patients show no
more signs of this alteration; so they return to
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a normal state like control subjects. This result
is confirmed also by the fact that our subjects,
even if treated with vincristine, did not mani-
fested  any  neuropathy  like  Pal  reported.13
However  it  could  be  possible  that  these
changes depend on other factors different from
chemotherapy. The results confirm that auto-
nomic changes in patients with lymphoma may
represent a paraneoplastic disease.            
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Table 1. General characteristics of Hodgkin and non-Hodgkin subjects and controls.
Hodgkin and non Hodgking subjects Controls
Age (years) 58.7±7.3 59.5±6.7
Gender (%males) 50 % 50%
Diabetes mellitus 1.6% 2.4%
Hypertension 2.4% 3.2%
Table 2. Results of autonomic tests in the study groups (Current vs. Cured patients).
Test Parameter Current pts (n°22) Cured pts (n°40)
Deep breathing E/I ratio 1.1±0.03 1.4±0.04*
Valsalva maneuver Valsalva ratio 1.3±0.1 1.9±0.1 *
Hand grip test Diastolic blood pressure  19.1±3.1 23.3±3.1
increase in mmHg
Laying to standing test Systolic blood pressure -5.2±6.2 -3.4±4.5
decrease in mmHg
Tilt test RR intervals 1.08±0.01 1.2±0.03
*P<0.05
Table 3. Results of autonomic tests in the study groups (Current patients vs Healthy sub-
jects).
Test Parameter Current pts (n°22) Cured pts (n°18)
Deep breathing E/I ratio 1.1±0.03 1.42±0.02*
Valsalva maneuver Valsalva ratio 1.3±0.1 1.86±0.3 *
Hand grip test Diastolic blood pressure  19.1±3.1 20.4±4.7
increase in mmHg
Laying to standing test Systolic blood pressure -5.2±6.2 -5.5±4.6
decrease in mmHg
Tilt test RR intervals 1.08±0.01 1.12±0.01
*P<0.05
Table 4. Results of autonomic tests in the study group (Cured  vs. Healthy subjects).
Test Parameter Cured pts(n°18) Healthy(n°40)
Deep breathing E/I ratio 1.4±0.04 1.42±0.02
Valsalva maneuver Valsalva ratio 1.9±0.1 1.86±0.3
Hand grip test Diastolic blood pressure  23.3±3.1 20.4±4.7
increase in mmHg
Laying to standing test Systolic blood pressure -3.4±4.5 -5.5±4.6
decrease in mmHg
Tilt test RR intervals 1.2±0.03 -5.5±4.6